NICOLAS ELIZONDO: Open Payments
NPI 1518420314 · ANACORTES, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 16 payments from 9 companies in 2025. Trend: 2023 $429 · 2024 $364 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 4 | $90 |
| UCB, Inc. | 3 | $85 |
| Janssen Biotech, Inc. | 2 | $57 |
| Organon LLC | 2 | $40 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| LEO Pharma Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $17 |
| Galderma Laboratories, L.P. | 1 | $15 |
Products named: LIBTAYO, Bimzelx, TREMFYA, ILUMYA, COSENTYX, VTAMA, ANZUPGO, RINVOQ.
Industry payments across WA — which companies pay providers there.
